血清超敏C-反應(yīng)蛋白和降鈣素原與D-二聚體及纖維蛋白原在糖尿病足感染患者中的變化分析
[Abstract]:Objective to observe the changes of serum hypersensitive C-reactive protein (hs-CRP), procalcitonin (PCT), D-dimer and fibrinogen in patients with diabetic foot infection. Early prevention provides reference. Methods 159 cases of diabetic foot were selected from May 2014 to May 2016, including 71 cases of uninfected patients and 88 cases of infected patients, including 34 cases of mild infection, 33 cases of moderate infection and 21 cases of severe infection. The levels of hs-CRP, PCT, fibrinogen and D-dimer were detected by immunoturbidimetric assay, enzyme linked fluorescence assay and automatic hemagglutination analyzer respectively, and the difference of hs-CRP,PCT, fibrinogen and D-dimer levels were compared. Results there were significant differences in hs-CRP,PCT, fibrinogen and D-dimer levels between diabetic foot patients with different infection degree (P0.05). The levels of hs-CRP,PCT, fibrinogen and D-dimer in mild infection group, moderate infection group and severe infection group were significantly higher than those in non-infected group, and the level of hs-CRP,PCT, fibrinogen and D-dimer increased with the severity of infection. The levels of hs-CRP,PCT, fibrinogen and D-dimer in ineffective patients were significantly higher than those in cured patients (P0.05). By Pearson test, there was no correlation between hs-CRP,PCT, fibrinogen and D-dimer levels and sex, age and course of diabetes in 159 patients with diabetic foot. There was a significant correlation between serum inflammatory index hs-CRP,PCT and fibrinogen and D-dimer (P0.05). Conclusion inflammation and fibrinolysis play an important role in the development of diabetic foot infection. Hs-CRP,PCT, fibrinogen and D-dimer can be used to reflect the degree and treatment of diabetic foot infection.
【作者單位】: 鄭州人民醫(yī)院內(nèi)分泌科;
【分類號】:R587.2
【相似文獻(xiàn)】
相關(guān)期刊論文 前10條
1 劉佳寧;李英;康紅;何立彬;趙學(xué)玲;李恩麗;;急性中重度一氧化碳中毒患者血漿D-二聚體檢測的臨床意義[J];中國初級衛(wèi)生保健;2010年07期
2 王杰,黃肖耆,殷文金,秦志芳;SLE患者ACA與D-二聚體的檢測及意義[J];江蘇醫(yī)藥;1997年06期
3 李華;李思江;馮振東;葉樹新;;糖化血紅蛋白聯(lián)合D-二聚體和纖維蛋白原在2型糖尿病微血管病變中的應(yīng)用[J];國際檢驗(yàn)醫(yī)學(xué)雜志;2013年11期
4 趙寶珍,郗光霞,梁樹芬,高春華;非胰島素依賴型糖尿病患者血漿D-二聚體的變化及其意義[J];山西醫(yī)藥雜志;1997年06期
5 龍兆豐,屈國云,徐敏;血漿D-二聚體與2型糖尿病微血管病變的關(guān)系[J];湖南醫(yī)科大學(xué)學(xué)報(bào);2001年05期
6 杜轉(zhuǎn)敏;楊毛吉;;類風(fēng)濕關(guān)節(jié)炎患者血漿D-二聚體水平測定及其臨床意義[J];藥物與人;2014年05期
7 王福黨 ,劉蘚茹,桑沛霞;SLE患者血漿GMP-140,D-二聚體檢測及意義[J];中國現(xiàn)代醫(yī)學(xué)雜志;2003年14期
8 祝繼華,邱大為,肖勤,汪志紅;2型糖尿病患者血漿D-二聚體的變化與血液流變和血脂的關(guān)系[J];重慶醫(yī)科大學(xué)學(xué)報(bào);2000年02期
9 李桂芳;糖尿病患者血漿D-二聚體檢測的臨床意義[J];華北煤炭醫(yī)學(xué)院學(xué)報(bào);2002年01期
10 高勇,唐振華,孫守攀;2型糖尿病患者血漿D-二聚體測定的臨床意義[J];蚌埠醫(yī)學(xué)院學(xué)報(bào);2000年03期
相關(guān)會議論文 前1條
1 薛曄霞;;糖尿病視網(wǎng)膜病變患者血漿D-二聚體及血液黏度指標(biāo)變化的分析[A];中華醫(yī)學(xué)會第十一次全國內(nèi)分泌學(xué)學(xué)術(shù)會議論文匯編[C];2012年
相關(guān)碩士學(xué)位論文 前5條
1 陳慧;Graves病與D-二聚體、C反應(yīng)蛋白的相關(guān)性研究[D];南昌大學(xué)醫(yī)學(xué)院;2015年
2 高一凱;急性百草枯中毒存活患者D-二聚體變化研究[D];山東大學(xué);2016年
3 陳莉貞;聯(lián)合CRP、D-二聚體、TB-IGRA檢測在艾滋病合并結(jié)核分枝桿菌感染診斷中的相關(guān)性研究[D];浙江大學(xué);2016年
4 許哲;可溶性I-A~b/Fc二聚體的優(yōu)化表達(dá)及純化[D];華中科技大學(xué);2013年
5 崔璐;2型糖尿病合并高血壓患者血漿D-二聚體及纖維蛋白原水平研究[D];浙江大學(xué);2008年
,本文編號:2380431
本文鏈接:http://sikaile.net/yixuelunwen/nfm/2380431.html